<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
<responseDate>2023-08-20T22:38:57Z</responseDate>
<request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7840891" metadataPrefix="pmc_fm">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
<GetRecord>
<record>
<header>
<identifier>oai:pubmedcentral.nih.gov:7840891</identifier>
<datestamp>2021-02-01</datestamp>
<setSpec>elsevierwt</setSpec>
<setSpec>pmc-open</setSpec>
</header>
<metadata>
<article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Oncol</journal-id>
<journal-title-group>
<journal-title>Annals of Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0923-7534</issn>
<issn pub-type="epub">1569-8041</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="accession">PMC7840891</article-id>
<article-id pub-id-type="pmcid">PMC7840891</article-id>
<article-id pub-id-type="pmc-uid">7840891</article-id>
<article-id pub-id-type="pmid">33248227</article-id>
<article-id pub-id-type="pii">S0923-7534(20)43168-0</article-id>
<article-id pub-id-type="doi">10.1016/j.annonc.2020.11.013</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Casolino</surname>
<given-names>R.</given-names>
</name>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="aff2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Braconi</surname>
<given-names>C.</given-names>
</name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Malleo</surname>
<given-names>G.</given-names>
</name>
<xref rid="aff3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Paiella</surname>
<given-names>S.</given-names>
</name>
<xref rid="aff3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author" id="au5">
<name>
<surname>Bassi</surname>
<given-names>C.</given-names>
</name>
<xref rid="aff3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author" id="au6">
<name>
<surname>Milella</surname>
<given-names>M.</given-names>
</name>
<xref rid="aff4" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author" id="au7">
<name>
<surname>Dreyer</surname>
<given-names>S.B.</given-names>
</name>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="aff5" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author" id="au8">
<name>
<surname>Froeling</surname>
<given-names>F.E.M.</given-names>
</name>
<xref rid="aff6" ref-type="aff">6</xref>
</contrib>
<contrib contrib-type="author" id="au9">
<name>
<surname>Chang</surname>
<given-names>D.K.</given-names>
</name>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="aff5" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author" id="au10">
<name>
<surname>Biankin</surname>
<given-names>A.V.</given-names>
</name>
<email>andrew.biankin@glasgow.ac.uk</email>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="aff5" ref-type="aff">5</xref>
<xref rid="aff7" ref-type="aff">7</xref>
<xref rid="cor1" ref-type="corresp">∗</xref>
</contrib>
<contrib contrib-type="author" id="au11">
<name>
<surname>Golan</surname>
<given-names>T.</given-names>
</name>
<xref rid="aff8" ref-type="aff">8</xref>
</contrib>
<aff id="aff1">
<label>1</label>
Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Bearsden, Glasgow, Scotland, UK
</aff>
<aff id="aff2">
<label>2</label>
Department of Medicine, University and Hospital Trust of Verona, Verona, Italy
</aff>
<aff id="aff3">
<label>3</label>
Department of Surgery, University and Hospital Trust of Verona, Verona, Italy
</aff>
<aff id="aff4">
<label>4</label>
Department of Medicine, Medical Oncology, University and Hospital Trust of Verona, Verona (VR), Italy
</aff>
<aff id="aff5">
<label>5</label>
West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK
</aff>
<aff id="aff6">
<label>6</label>
Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK
</aff>
<aff id="aff7">
<label>7</label>
South Western Sydney Clinical School, Faculty of Medicine, University of NSW, Liverpool, NSW, Australia
</aff>
<aff id="aff8">
<label>8</label>
Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<label>∗</label>
<italic>Correspondence to:</italic>
Prof. Andrew V. Biankin, Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK. Tel: +44-141-330-5670; Fax: +44-141-330-5834
<email>andrew.biankin@glasgow.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>2</month>
<year>2021</year>
</pub-date>
<!--  PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">. -->
<pub-date pub-type="ppub">
<month>2</month>
<year>2021</year>
</pub-date>
<volume>32</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>196</lpage>
<permissions>
<copyright-statement>© 2020 The Authors</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>This review summarises the recent evidence on preoperative therapeutic strategies in pancreatic cancer and discusses the rationale for an imminent need for a personalised therapeutic approach in non-metastatic disease. The molecular diversity of pancreatic cancer and its influence on prognosis and treatment response, combined with the failure of ‘all-comer’ treatments to significantly impact on patient outcomes, requires a paradigm shift towards a genomic-driven approach. This is particularly important in the preoperative, potentially curable setting, where a personalised treatment allocation has the substantial potential to reduce pancreatic cancer mortality.</p>
</abstract>
<abstract abstract-type="author-highlights" id="abs0015">
<title>Highlights</title>
<p>
<list list-type="simple" id="ulist0010">
<list-item id="u0010">
<label>•</label>
<p id="p0010">Molecular diversity of pancreatic cancer requires a paradigm shift towards a genomic-driven therapeutic approach.</p>
</list-item>
<list-item id="u0015">
<label>•</label>
<p id="p0015">Unselected treatment strategies demonstrate only limited efficacy in early-stage pancreatic cancer.</p>
</list-item>
<list-item id="u0020">
<label>•</label>
<p id="p0020">Personalised treatment in non-metastatic disease has potential to reduce pancreatic cancer mortality.</p>
</list-item>
<list-item id="u0025">
<label>•</label>
<p id="p0025">It is fundamental to implement preoperative clinical studies enriched for potential prognostic/predictive biomarkers.</p>
</list-item>
<list-item id="u0030">
<label>•</label>
<p id="p0030">Novel models of therapeutic development are warranted to accelerate progress in pancreatic cancer care and research.</p>
</list-item>
</list>
</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Key words</title>
<kwd>Pancreatic cancer</kwd>
<kwd>preoperative</kwd>
<kwd>neoadjuvant</kwd>
<kwd>precision medicine</kwd>
<kwd>prognostic biomarkers</kwd>
<kwd>predictive biomarkers</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
